Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000802065 | SCV000941878 | uncertain significance | Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 11 | 2022-06-07 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 72 of the RAPSN protein (p.Thr72Met). This variant is present in population databases (rs770633491, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with RAPSN-related conditions. ClinVar contains an entry for this variant (Variation ID: 647539). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002495080 | SCV002777437 | uncertain significance | Congenital myasthenic syndrome 11; Fetal akinesia deformation sequence 2 | 2022-01-04 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003133628 | SCV003813708 | uncertain significance | not provided | 2020-11-19 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001275250 | SCV001460222 | uncertain significance | Congenital myasthenic syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |